Cargando…

Skin Phototype Could Be a Risk Factor for Multiple Sclerosis

Environmental and genetic factors are assumed to be necessary for the development of multiple sclerosis (MS), however its interactions are still unclear. For this reason here, we have not only analyzed the impact on increased risk of MS of the best known factors (HLA-DRB1*15:01 allele, sun exposure,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Urbaneja, Patricia, Hurtado-Guerrero, Isaac, Hernández, Miguel Ángel, Oliver-Martos, Begoña, Oreja-Guevara, Celia, Ortega-Pinazo, Jesús, Alonso, Ana, Barón-López, Francisco J, Leyva, Laura, Fernández, Óscar, Pinto-Medel, María Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464407/ https://www.ncbi.nlm.nih.gov/pubmed/32722577 http://dx.doi.org/10.3390/jcm9082384

Ejemplares similares

Global methylation correlates with clinical status in multiple sclerosis patients in the first year of IFNbeta treatment
por: Pinto-Medel, María Jesús, et al.
Publicado: (2017)

Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2017)

Activation of the JAK-STAT Signaling Pathway after In Vitro Stimulation with IFNß in Multiple Sclerosis Patients According to the Therapeutic Response to IFNß
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2017)

TRAIL and TRAIL receptors splice variants during long-term interferon β treatment of patients with multiple sclerosis: evaluation as biomarkers for therapeutic response
por: López-Gómez, Carlos, et al.
Publicado: (2016)

TRAIL/TRAIL Receptor System and Susceptibility to Multiple Sclerosis
por: López-Gómez, Carlos, et al.
Publicado: (2011)

Candidate Gene Study of TRAIL and TRAIL Receptors: Association with Response to Interferon Beta Therapy in Multiple Sclerosis Patients
por: López-Gómez, Carlos, et al.
Publicado: (2013)

Central Centrifugal Cicatricial Alopecia in a Fair Phototype Patient
por: Fernandez-Nieto, Diego, et al.
Publicado: (2019)

Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation
por: Hurtado-Guerrero, Isaac, et al.
Publicado: (2020)

Soluble Receptor Isoform of IFN-Beta (sIFNAR2) in Multiple Sclerosis Patients and Their Association With the Clinical Response to IFN-Beta Treatment
por: Aliaga-Gaspar, Pablo, et al.
Publicado: (2021)

Validity of the Fitzpatrick Skin Phototype Classification in Ecuador
por: Fors, Martha, et al.
Publicado: (2020)

Dermoscopy of facial angiofibromas in Fitzpatrick II‐III phototype subjects affected by tuberous sclerosis complex
por: Lacarrubba, Francesco, et al.
Publicado: (2023)

Characterizing Skin Cancer in Transplant Recipients by Fitzpatrick Skin Phototype
por: Shope, Chelsea N., et al.
Publicado: (2022)

The frequency of reporting race, ethnicity, and skin phototypes in dermatology case reports
por: Chung, Hye Jin, et al.
Publicado: (2023)

Pediatric rosacea in a patient with a dark phototype: Clinical and dermoscopic features
por: Chabchoub, Ines, et al.
Publicado: (2020)

Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel
por: Passeron, T., et al.
Publicado: (2021)

Cognitive Dysfunctions and Assessments in Multiple Sclerosis
por: Oreja-Guevara, Celia, et al.
Publicado: (2019)

Dermoscopy of Annular Atrophic Lichen Planus on a Dark Phototype: A Case Series
por: Kelati, Awatef, et al.
Publicado: (2023)

Optical Coherence Tomography in Multiple Sclerosis and Neuromyelitis Optica: An Update
por: Noval, Susana, et al.
Publicado: (2011)

Predictive factors and early biomarkers of response in multiple sclerosis patients treated with natalizumab
por: Dominguez-Mozo, Maria Inmaculada, et al.
Publicado: (2020)

Diagnosis and treatment of progressive multiple sclerosis: A position paper
por: Pozzilli, Carlo, et al.
Publicado: (2022)

Photoreactivity of Hair Melanin from Different Skin Phototypes—Contribution of Melanin Subunits to the Pigments Photoreactive Properties
por: Mokrzynski, Krystian, et al.
Publicado: (2021)

Influence of Skin Phototype on the Level of Pain Perceived by Patients Receiving Enoxaparin: A Cross-Sectional Study
por: Díaz-González, Candelaria de la Merced, et al.
Publicado: (2022)

Lichen Planus and Lichen Planus Pigmentosus Inversus Following COVID-19 Vaccine in Dark Phototype Patients
por: Gil-Quiñones, S.R., et al.
Publicado: (2023)

TH1/TH2 Cytokine profile in relapsing-remitting multiple sclerosis patients treated with Glatiramer acetate or Natalizumab
por: Oreja-Guevara, Celia, et al.
Publicado: (2012)

Pigmentation phototype and prostate and breast cancer in a select Spanish population—A Mendelian randomization analysis in the MCC-Spain study
por: Gómez-Acebo, Inés, et al.
Publicado: (2018)

Spectroscopic and Imaging Characteristics of Pigmented Non-Melanoma Skin Cancer and Melanoma in Patients with Skin Phototypes III and IV
por: Arroyo-Camarena, Stefanie, et al.
Publicado: (2016)

Skin Phototype and Disease: A Comprehensive Genetic Approach to Pigmentary Traits Pleiotropy Using PRS in the GCAT Cohort
por: Farré, Xavier, et al.
Publicado: (2023)

Clinically Isolated Syndromes Suggestive of Multiple Sclerosis: An Optical Coherence Tomography Study
por: Oreja-Guevara, Celia, et al.
Publicado: (2012)

Treatment with natalizumab during the Covid-19 pandemic in multiple sclerosis patients
por: Díaz-Díaz, Judit, et al.
Publicado: (2021)

Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism
por: Ramos-Cejudo, Jaime, et al.
Publicado: (2011)

Folliculitis Decalvans with Frontal Fibrosing Alopecia in a Dark Phototype: Presentation of Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum
por: Karrakchou, Basma, et al.
Publicado: (2023)

Family Planning in Fertile-Age Patients With Multiple Sclerosis (MS) (ConPlanEM Study): Delphi Consensus Statements
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
por: Schmierer, Klaus, et al.
Publicado: (2022)

Amyloid Proteins and Their Role in Multiple Sclerosis. Considerations in the Use of Amyloid-PET Imaging
por: Matías-Guiu, Jordi A., et al.
Publicado: (2016)

Assisted Reproductive Techniques in Multiple Sclerosis: Recommendations from an Expert Panel
por: Oreja-Guevara, Celia, et al.
Publicado: (2023)

Prevalence of vitamin D deficiency during the summer and its relationship with sun exposure and skin phototype in elderly men living in the tropics
por: Cabral, Marcelo Azevedo, et al.
Publicado: (2013)

Is natalizumab a safe treatment for patients with multiple sclerosis in the COVID-19 pandemic? Data from the first year of the pandemic
por: Díaz-Díaz, Judit, et al.
Publicado: (2021)

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts
por: Berger, Thomas, et al.
Publicado: (2016)

Natalizumab-immunogenicity evaluation in patients with infusion related events or disease exacerbations
por: Ciano-Petersen, Nicolás Lundahl, et al.
Publicado: (2023)

Comparative Study of Δ9-Tetrahydrocannabinol and Cannabidiol on Melanogenesis in Human Epidermal Melanocytes from Different Pigmentation Phototypes: A Pilot Study
por: Goenka, Shilpi
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9uvvp6ecs26a22bfhadvs24elk